Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum
- PMID: 240136
- DOI: 10.1007/BF00508415
Acute and subacute effects of neuroleptics dopamine synthesis and release in the rat striatum
Abstract
The effects of acute and subacute treatments with moderate doses of thioproperazine and haloperidol on dopamine synthesis and release have been examined in rat striatal slices. Synthesis and release of dopamine were determined by measuring the rate of formation of 3H-H2O during the conversion of L3,5-3H-tyrosine into 3H-Dopa and the accumulation of newly synthesized 3H-dopamine in striatal slices and their incubating medium. Possible effects of the treatments on tyrosine striatal levels or tyrosine specific activity were also investigated. Dopamine synthesis rate was markedly accelerated 2.5 hrs after the acute injection of thioproperazine, but was equal to control levels 24 hrs later. The effects of thioproperazine and haloperidol were thus determined 2.5 and 24 hrs after an acute injection and following the last injection of a repeated daily treatment of 11 days. Dopamine synthesis and release were still markedly increased 2.5 hrs after the last injection of the subacute neuroleptic treatments when compared to controls, but these effects were less pronounced than those observed 2.5 hrs after an acute injection of either drug. Conversely, dopamine synthesis and release were significantly decreased 24 hrs after the last injection of the subacute neuroleptic treatments when compared to controls. Two hypotheses are proposed to explain the changes in dopamine synthesis induced by repeated treatments with neurolptics.
Similar articles
-
Inhibition of striatal dopamine synthesis in rats injected chronically with neuroleptics in their early life.Naunyn Schmiedebergs Arch Pharmacol. 1975;288(1):97-102. doi: 10.1007/BF00501817. Naunyn Schmiedebergs Arch Pharmacol. 1975. PMID: 240129
-
Decrease in the evoked release of endogenous dopamine and dihydroxyphenylacetic acid from rat striatal slices after withdrawal from repeated haloperidol.Eur J Pharmacol. 1990 Nov 27;191(2):149-55. doi: 10.1016/0014-2999(90)94142-k. Eur J Pharmacol. 1990. PMID: 2086236
-
The effect of blocking dopamine release on synthesis rate of dopamine in the striatum of the rat.Eur J Pharmacol. 1975 Sep-Oct;33(2):247-54. doi: 10.1016/0014-2999(75)90168-5. Eur J Pharmacol. 1975. PMID: 171162
-
Chronic treatment with haloperidol modifies the sensitivity of autoreceptors that modulate dopamine release in rat striatum.Eur J Pharmacol. 1993 Feb 23;232(1):1-6. doi: 10.1016/0014-2999(93)90720-3. Eur J Pharmacol. 1993. PMID: 8458389
-
Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosine.Pharmacol Ther B. 1976;2(1):49-63. doi: 10.1016/0306-039x(76)90018-0. Pharmacol Ther B. 1976. PMID: 772722 Review. No abstract available.
Cited by
-
Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.Naunyn Schmiedebergs Arch Pharmacol. 1978 Jul;303(3):271-8. doi: 10.1007/BF00498054. Naunyn Schmiedebergs Arch Pharmacol. 1978. PMID: 567284
-
Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.Psychopharmacology (Berl). 1990;101(2):168-71. doi: 10.1007/BF02244121. Psychopharmacology (Berl). 1990. PMID: 2140903
-
Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration.Psychopharmacology (Berl). 1986;88(1):63-5. doi: 10.1007/BF00310514. Psychopharmacology (Berl). 1986. PMID: 2868484
-
Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.J Neural Transm (Vienna). 2010 May;117(5):573-83. doi: 10.1007/s00702-010-0396-5. Epub 2010 Apr 6. J Neural Transm (Vienna). 2010. PMID: 20372943
-
Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.Psychopharmacology (Berl). 1978 Dec 8;59(3):211-6. doi: 10.1007/BF00426624. Psychopharmacology (Berl). 1978. PMID: 32570 No abstract available.